Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Evolving biomarkers in metastatic disease: Liquid, solid or both?

AI in oncology: Understanding the limits and challenges of data and model deployment

Date

14 Sep 2024

Session

Evolving biomarkers in metastatic disease: Liquid, solid or both?

Topics

Pathology/Molecular Biology;  Cancer Intelligence (eHealth, Telehealth Technology, BIG Data)

Tumour Site

Breast Cancer

Presenters

Anita Grigoriadis

Authors

A. Grigoriadis

Author affiliations

  • School Of Cancer Studies, King's College London Guy's Hospital - NHS Foundation Trust, SE1 9RT - London/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: Evolving biomarkers in metastatic disease: Liquid, solid or both?

Resources:

Webcast

Conclusions and perspectives

Presenter: Sandra Ximena Franco Millan

Session: Evolving biomarkers in metastatic disease: Liquid, solid or both?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.